Quantcast

More Than 17 Million Flu Vaccine Doses Shipped In Six Weeks

HHS Secretary Tommy G. Thompson announced today that 17.2 million influenza vaccine doses have been shipped in the last six weeks to health providers serving high-priority groups as part of the program to reallocate the vaccine to those areas and people who need it most. The Secretary also said that the Food and Drug Administration (FDA) has nearly completed its examination of vaccines from foreign manufacturers.

From U.S. HHS:

More Than 17 Million Flu Vaccine Doses Shipped In Six Weeks

Secretary Says Decision On Vaccine From Foreign Manufacturers Expected Soon

HHS Secretary Tommy G. Thompson announced today that 17.2 million influenza vaccine doses have been shipped in the last six weeks to health providers serving high-priority groups as part of the program to reallocate the vaccine to those areas and people who need it most. The Secretary also said that the Food and Drug Administration (FDA) has nearly completed its examination of vaccines from foreign manufacturers.

”Working together, our public health community has done an outstanding job of directing the vaccine to those who need it most,” Secretary Thompson said. ”I commend those healthy individuals who are not in high priority groups for stepping aside in a true spirit of cooperation to help keep vulnerable Americans healthy this year.”

This week’s shipments are part of the Centers for Disease Control and Prevention’s (CDC)) and Aventis Pasteur’s plan to ensure vaccine is getting shipped to groups serving high-priority populations. Those groups include the Department of Defense, the Veteran’s Administration, long term and acute care hospitals, private physicians who care for high priority populations, Vaccine for Children Program participants, and the Indian Health Service.

Early indications show the allocation plan is working, with vaccine going to those who need it most. An initial survey conducted recently by the Association of State and Territorial Health Officials (ASTHO) and CDC indicates a high demand for vaccine still exists in some areas, but a few states report a small amount of vaccine in excess of their needs. Plans are underway to reapportion this small amount of vaccine to other states. ASTHO and CDC plan on conducting a follow up survey to further assess the situation in early December.

In addition, several million more doses of vaccine are scheduled to be shipped each week through early December. Influenza usually peaks sometime between December and March so it’s not too late for those who need a vaccine to receive one. Although influenza activity is difficult to predict, early reports indicate that this year’s season is off to a slower start compared to last year. Thirty-two states have reported influenza activity to CDC thus far, which is well within the range of activity that might be expected for this time of year.

Secretary Thompson also said FDA intends to make an announcement next week about the influenza vaccine it has identified from foreign manufacturers that could potentially be available under investigational new drug applications. FDA has completed its inspections of the sponsors’ manufacturing facilities and is currently evaluating the information from these inspections together with other information submitted by the companies to determine if their products are appropriate for investigational use.

The additional vaccine would be in addition to the existing supply of 61 million doses of influenza vaccine, which includes about 58 million doses of Aventis injectible vaccine and 3 million doses of FluMist nasal spray.

Additionally, the federal government has purchased and stockpiled antiviral medicines to treat more than 7 million people. Supplies of antiviral medicines also exist in the private sector and manufacturers indicate that they have the ability to significantly ramp up production. All told, between existing stockpiles, private sector supplies and production capabilities, the FDA estimates there could be enough medicine to treat tens of millions of people through the heart of flu season.

CDC encourages those in high-priority groups to continue to check with their local health official about availability of vaccine. Individuals who are having difficulty finding vaccine or who want additional information on influenza can call CDC’s hotline at 1-800-CDC-INFO. The high-priority groups include:

? All children aged 6-23 months.

? Adults aged 65 years and older.

? People aged 2-64 years with underlying chronic medical conditions.

? All women who will be pregnant during influenza season.

? Residents of nursing homes and long-term care facilities.

? Children 6 months to 18 years of age on chronic aspirin therapy.

? Health-care workers with direct patient care.

? Out-of-home caregivers and household contacts of children aged <6 months.

Finally, everyone can take practical steps to help prevent spread of flu, including:

? Avoid close contact with people who are sick.

? Keep your distance from others if you are sick.

? When possible, stay home from work, school, and errands when you are sick, and don't send your children to child care or school if they are sick.

? Cover your mouth and nose when coughing or sneezing.

? Clean your hands often.

For more information about the flu, visit the CDC Web site: www.cdc.gov/flu.




The material in this press release comes from the originating research organization. Content may be edited for style and length. Want more? Sign up for our daily email.